GNMLF (Genomma Lab InternacionalB de CV) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GNMLF Genomma Lab Internacional SAB de CV GNMLF
53 GF Score
Price $0.77
GF Value $0.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV FFO per Share?

FFO per Share only applies to REITs.

GNMLF
53GF Score
Genomma Lab Internacional SAB de CV GNMLF
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genomma Lab InternacionalB de CV (GNMLF) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of $0.77 is trading 21.4% below its estimated GF Value™ of $0.98. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for GNMLF:

  • FFO per Share:
  • GF Value™: $0.98 vs. price of $0.77 (21.4% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the GNMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomma Lab InternacionalB de CV Business Description

Other Exchanges LABB:MexicoGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a Mexican consumer healthcare and personal care company. It develops, markets, and sells over-the-counter pharmaceuticals and personal care products, primarily under its own brands, rather than acting as a traditional pharmaceutical manufacturer. Its portfolio spans categories such as pain relief, cold and flu, gastrointestinal, dermatological, and feminine care products, along with personal care items including deodorants and hair care. Well-known brands include Tio Nacho, Medicasp, Next, and Asepxia. The company sells mainly through mass-market retailers, pharmacies, and supermarkets, targeting consumers across Mexico and other Latin American markets, as well as the United States and parts of Europe. Revenue is generated primarily from product sales through retail distribution channels, supported by advertising and brand-building. Genomma Lab has pursued acquisitions to expand its brand portfolio and geographic reach.
53GF Score

Get the complete analysis for GNMLF

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.77
Price
$0.98
GF Value